Document Detail


Endocardial radiofrequency ablation for hypertrophic obstructive cardiomyopathy acute results and 6 months' follow-up in 19 patients.
MedLine Citation:
PMID:  21272748     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVES: The purpose of this study was to examine the efficacy and safety of endocardial radiofrequency ablation of septal hypertrophy (ERASH) for left ventricular outflow tract (LVOT) gradient reduction in hypertrophic obstructive cardiomyopathy (HOCM).
BACKGROUND: Anatomic variability of the vessels supplying the obstructing septal bulge can limit the efficacy of transcoronary ablation of septal hypertrophy in HOCM. Previous studies showed that inducing a local contraction disorder without reducing septal mass results in effective gradient reduction. We examined an alternative endocardial approach to transcoronary ablation of septal hypertrophy by using ERASH.
METHODS: Nineteen patients with HOCM were enrolled; in 9 patients, the left ventricular septum was ablated, and in 10 patients, the right ventricular septum was ablated. Follow-up examinations (echocardiography, 6-min walk test, bicycle ergometry) were performed 3 days and 6 months after ERASH.
RESULTS: After 31.2 ± 10 radiofrequency pulses, a significant and sustained LVOT gradient reduction could be achieved (62% reduction of resting gradients and 60% reduction of provoked gradients, p = 0.0001). The 6-min walking distance increased significantly from 412.9 ± 129 m to 471.2 ± 139 m after 6 months, p = 0.019); and New York Heart Association functional class was improved from 3.0 ± 0.0 to 1.6 ± 0.7 (p = 0.0001). Complete atrioventricular block requiring permanent pacemaker implantation occurred in 4 patients (21%); 1 patient had cardiac tamponade.
CONCLUSIONS: ERASH is a new therapeutic option in the treatment of HOCM, allowing significant and sustained reduction of the LVOT gradient as well as symptomatic improvement with acceptable safety by inducing a discrete septal contraction disorder. It may be suitable for patients not amenable to transcoronary ablation of septal hypertrophy or myectomy.
Authors:
Thorsten Lawrenz; Bianca Borchert; Christian Leuner; Markus Bartelsmeier; Jens Reinhardt; Claudia Strunk-Mueller; Dorothee Meyer Zu Vilsendorf; Marc Schloesser; Gerald Beer; Frank Lieder; Christoph Stellbrink; Horst Kuhn
Related Documents :
17010458 - Cardiac troponin i release in non-ischemic reversible myocardial injury from parvovirus...
21450598 - Health and cost consequences of early versus late invasive strategy after thrombolysis ...
10510058 - Acute right ventricular restrictive physiology after repair of tetralogy of fallot: ass...
17670518 - Effect of topic defibrillation on serum markers of myocardial damage.
24406108 - Comparison of endovascular versus epicardial lead placement for resynchronization therapy.
1728498 - Role of invasive electrophysiological testing in the evaluation and treatment of patien...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  57     ISSN:  1558-3597     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  572-6     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Affiliation:
Department of Cardiology, Klinikum Bielefeld, Bielefeld, Germany; Department of Cardiology, University of Witten/Herdecke, Witten, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevention and reversal of atrial fibrillation inducibility and autonomic remodeling by low-level va...
Next Document:  Obesity induces signs of premature cardiac aging in younger patients the role of mitochondria.